Lenalidomide Maintenance Therapy in Multiple Myeloma: A Phase II Clinical and Biomarker Study
Phase of Trial: Phase II
Latest Information Update: 07 Feb 2018
At a glance
- Drugs Lenalidomide (Primary)
- Indications Multiple myeloma
- Focus Biomarker; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 08 Jan 2018 Status changed from completed to discontinued.
- 11 Mar 2017 Status changed from active, no longer recruiting to completed.